BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 33568995)

  • 1. Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines.
    Abdullah-Koolmees H; van Keulen AM; Nijenhuis M; Deneer VHM
    Front Pharmacol; 2020; 11():595219. PubMed ID: 33568995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
    García-González X; Salvador-Martín S
    J Pers Med; 2021 Nov; 11(11):. PubMed ID: 34834533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.
    Brouwer JMJL; Nijenhuis M; Soree B; Guchelaar HJ; Swen JJ; van Schaik RHN; Weide JV; Rongen GAPJM; Buunk AM; de Boer-Veger NJ; Houwink EJF; van Westrhenen R; Wilffert B; Deneer VHM; Mulder H
    Eur J Hum Genet; 2022 Oct; 30(10):1114-1120. PubMed ID: 34782755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan.
    Hulshof EC; Deenen MJ; Nijenhuis M; Soree B; de Boer-Veger NJ; Buunk AM; Houwink EJF; Risselada A; Rongen GAPJM; van Schaik RHN; Touw DJ; van der Weide J; van Westrhenen R; Deneer VHM; Guchelaar HJ; Swen JJ
    Eur J Hum Genet; 2023 Sep; 31(9):982-987. PubMed ID: 36443464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC
    Blazy C; Ellingrod V; Ward K
    Front Pharmacol; 2022; 13():939313. PubMed ID: 35814245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.
    Caudle KE; Sangkuhl K; Whirl-Carrillo M; Swen JJ; Haidar CE; Klein TE; Gammal RS; Relling MV; Scott SA; Hertz DL; Guchelaar HJ; Gaedigk A
    Clin Transl Sci; 2020 Jan; 13(1):116-124. PubMed ID: 31647186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Application of Pharmacogenetics: Where are We Now?
    van Schaik RH;
    EJIFCC; 2013 Feb; 24(3):105-12. PubMed ID: 27683445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
    Cecchin E; De Mattia E; Ecca F; Toffoli G
    Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics.
    Beunk L; Nijenhuis M; Soree B; de Boer-Veger NJ; Buunk AM; Guchelaar HJ; Houwink EJF; Risselada A; Rongen GAPJM; van Schaik RHN; Swen JJ; Touw D; van Westrhenen R; Deneer VHM; van der Weide J
    Eur J Hum Genet; 2024 Mar; 32(3):278-285. PubMed ID: 37002327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence based drug dosing and pharmacotherapeutic recommendations per genotype.
    Deneer VH; van Schaik RH
    Methods Mol Biol; 2013; 1015():345-54. PubMed ID: 23824868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation sequencing-based clinical pharmacogenomics data.
    Kordou Z; Skokou M; Tsermpini EE; Chantratita W; Fukunaga K; Mushiroda T; Patrinos GP; Koromina M
    Pharmacol Res; 2021 May; 167():105538. PubMed ID: 33705851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Policy and Practice Review: A First Guideline on the Use of Pharmacogenetics in Clinical Psychiatric Practice.
    van Westrhenen R; van Schaik RHN; van Gelder T; Birkenhager TK; Bakker PR; Houwink EJF; Bet PM; Hoogendijk WJG; van Weelden-Hulshof MJM
    Front Pharmacol; 2021; 12():640032. PubMed ID: 33995044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs.
    Manson LEN; Nijenhuis M; Soree B; de Boer-Veger NJ; Buunk AM; Houwink EJF; Risselada A; Rongen GAPJM; van Schaik RHN; Swen JJ; Touw DJ; van Westrhenen R; Deneer VHM; Guchelaar HJ
    Eur J Hum Genet; 2024 Apr; ():. PubMed ID: 38570725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT).
    Li B; Sangkuhl K; Keat K; Whaley RM; Woon M; Verma S; Dudek S; Tuteja S; Verma A; Whirl-Carrillo M; Ritchie MD; Klein TE
    Clin Pharmacol Ther; 2023 May; 113(5):1036-1047. PubMed ID: 36350094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.
    Caudle KE; Klein TE; Hoffman JM; Muller DJ; Whirl-Carrillo M; Gong L; McDonagh EM; Sangkuhl K; Thorn CF; Schwab M; Agundez JA; Freimuth RR; Huser V; Lee MT; Iwuchukwu OF; Crews KR; Scott SA; Wadelius M; Swen JJ; Tyndale RF; Stein CM; Roden D; Relling MV; Williams MS; Johnson SG
    Curr Drug Metab; 2014 Feb; 15(2):209-17. PubMed ID: 24479687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
    Pritchard D; Patel JN; Stephens LE; McLeod HL
    Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacogenetics of aminoglycoside ototoxicity: State of knowledge and practices - Recommendations of the Francophone Network of Pharmacogenetics (RNPGx)].
    Lebreton L; Hennart B; Baklouti S; Trimouille A; Boyer JC; Becquemont L; Dhaenens CM; Picard N
    Therapie; 2024 Jun; ():. PubMed ID: 38876950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate.
    Nijenhuis M; Soree B; Jama WOM; de Boer-Veger NJ; Buunk AM; Guchelaar HJ; Houwink EJF; Rongen GA; van Schaik RHN; Swen JJ; Touw D; van der Weide J; van Westrhenen R; Deneer VHM; Risselada A
    Eur J Hum Genet; 2023 Dec; 31(12):1364-1370. PubMed ID: 36509836
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Molden E; Jukić MM
    Front Pharmacol; 2021; 12():650750. PubMed ID: 33967790
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.